| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $424.3M | +68.0% |
| Cost of Revenue | $51.7M | +72.4% |
| Gross Profit | $372.7M | +67.4% |
| R&D Expense | $156.1M | +60.6% |
| SG&A Expense | $117.9M | +85.3% |
| Operating Income | -$211.4M | -63.9% |
| Pre-tax Income | -$175.3M | -10.2% |
| Income Tax | $2.9M | +291.8% |
| Net Income | -$172.3M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $295.4M | -66.6% |
| Accounts Receivable | $130.5M | +68.9% |
| Current Assets | $1.12B | +6.3% |
| Total Assets | $1.17B | +7.1% |
| Current Liabilities | $306.3M | +26.8% |
| Total Liabilities | $344.5M | +17.9% |
| Stockholders' Equity | $771.0M | -0.5% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.4M | -55.4% |
| Capital Expenditures | $6.1M | +71.4% |
| Investing Cash Flow | -$605.7M | -1023.8% |
| Financing Cash Flow | $97.5M | -86.1% |
| Free Cash Flow | -$83.5M | -56.5% |
| -11.1% |
| EPS (Basic) | -$1.16 | +40.5% |
| EPS (Diluted) | -$1.16 | +40.5% |